Us Bancorp »

Acelyrin shares owned by Us Bancorp

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-03-31 $36k 5.3k 6.75
2023-09-30 $324 32 10.16
2023-06-30 $3.9k 186 20.90

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Ishares Tr Rus Mid Cap Etf (IWR)
Eli Lilly & Co. (LLY)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
JPMorgan Chase & Co. (JPM)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Us Bancorp

Top funds holding Acelyrin

Citadel Advisors
FMR
Vanguard Group
BlackRock
Millennium Management
OrbiMed Advisors
venBio Partners
Adage Capital Partners GP
General Atlantic
Blue Owl Capital Holdings
Jpmorgan Chase & Co
Samsara BioCapital
Artal Group
T. Rowe Price Investment Management
Franklin Resources

View all funds holding Acelyrin